Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Área temáticas
Medicina y salud(3)
Farmacología y terapéutica(2)
Derecho(1)
Medicina forense; incidencia de enfermedades(1)
Salud y seguridad personal(1)
Año de Publicación
2022(3)
Origen
scopus(3)
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
ArticleAbstract: To date, no information has been published on the effectiveness of inactivated whole-virus COVID-19Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.Fuentes:scopusEffectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
ArticleAbstract: Background: COVID-19 vaccines have proven highly effective among individuals without a previous SARSPalabras claves:Autores:Andrews J.R., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Croda J., Cummings D.A.T., de Araujo Oliveira V., Dean N.E., Dorion M., Hitchings M.D.T., Júnior J.B.S., Ko A.I., Lind M.L., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Ranzani O.T., Werneck G.L.Fuentes:scopusVaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
ArticleAbstract: There is considerable interest in the waning of effectiveness of coronavirus disease 2019 (COVID-19)Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Flores-Ortiz R.J., Júnior J.B.S., Katikireddi S.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Robertson C., Sheikh A., Werneck G.L.Fuentes:scopus